Search the Newsreel

TEC reduces pressure on support teams with proactive outage communications powered by Adtran and GOCare

TEC has significantly improved its outage responses and reduced inbound support calls by implementing GOCare's OutageIQ solution, integrated with Adtran's outage notification API and Mosaic One. This integration allows TEC to proactively inform subscribers of service disruptions, enhancing customer trust and streamlining support operations. …

24,967 Shares in Medtronic PLC $MDT Acquired by First Bank & Trust

First Bank & Trust recently acquired 24,967 shares of Medtronic PLC (NYSE: MDT), valued at approximately $1.95 million. This purchase is part of a trend of institutional investment, as 82.06% of Medtronic's stock is held by institutional investors. Analysts generally maintain a "Moderate Buy" …

Medtronic (MDT) Stock Looks Fairly Valued On Cash Flow But Cheap On Earnings

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

In the latest close session, Medtronic (MDT) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%. The medical device company's stock has climbed by …

ADTRAN Holdings (ADTN) resets CTO contract with new long-term PSU caps

ADTRAN Holdings, through its subsidiary Adtran Networks SE, amended CTO Christoph Glingener's employment agreement. The amendment extends his term through December 31, 2026, maintains his €400,000 base salary, and updates his incentive structure to include new long-term financial plan performance stock unit (PSU) awards …

Medtronic (MDT) On New CE Mark Win And A Modest Undervalued View

Medtronic (MDT) recently received an expanded CE Mark for its Affera Mapping and Ablation System with Sphere-9 Catheter, leading to a recent positive share price momentum despite longer-term declines. The stock is considered modestly undervalued at $87.16 against a fair value of $90.37, supported …

Adtran Holdings, Inc.: Timothy Santo, Acquisition of 6,579 shares in ADTRAN Holdings, Inc. (ISIN US00486H1059)

Timothy Santo, the Chief Financial Officer of Adtran Holdings, Inc., has acquired 6,579 shares in the company (ISIN US00486H1059). The transaction, an acquisition, took place on August 6, 2026, at a price of 7.5999 USD per share, totaling 49,999.7421 USD. This notification serves as …

Is Medtronic (MDT) Becoming a Turnaround Story?

UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a "turnaround" is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or …

NewEdge Advisors LLC Trims Position in Medtronic PLC $MDT

NewEdge Advisors LLC has reduced its stake in Medtronic PLC (NYSE:MDT) by 12.4% during the first quarter, selling 25,953 shares and now holding 183,368 shares valued at $15.89 million. Despite this trim, several other institutional investors increased their positions in Medtronic. The article also …

Noticias de acciones de Medtronic PLC (MDT)

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Medtronic and Intuitive Surgical, two leading medical device companies, have faced challenges this year but are poised for a rebound. Medtronic offers a strong dividend yield and diversified product portfolio, while Intuitive Surgical leads the robotic-assisted surgery market with its innovative da Vinci system. …

Medtronic PLC (MDT) Stock Analysis & Forecast

This article provides an analysis and forecast for Medtronic PLC (MDT) stock. It includes recent stock performance data, key financial metrics, and mentions two in-depth analyses published by TradingKey. These analyses cover broader market trends and Medtronic's strategy for capitalizing on the aging global …

Medtronic PLC $MDT Shares Purchased by Gradient Investments LLC

Gradient Investments LLC increased its stake in Medtronic PLC (NYSE:MDT) by 3.9% during the second quarter, bringing its total holdings to 496,513 shares valued at approximately $38.8 million. Other institutional investors also adjusted their positions in the medical technology company, with 82.06% of the …

Medtronic PLC (MDT) Aktienanalyse & Prognose

Czech National Bank Acquires 16,292 Shares of Medtronic PLC $MDT

The Czech National Bank increased its stake in Medtronic PLC (NYSE:MDT) by 4.7% in the second quarter, purchasing an additional 16,292 shares, bringing its total holdings to 365,443 shares valued at approximately $28.6 million. Medtronic recently exceeded quarterly earnings expectations, reporting $1.55 in adjusted …

Dimensional Fund Advisors LP Buys 448,848 Shares of ADTRAN Holdings, Inc. $ADTN

Dimensional Fund Advisors LP significantly increased its stake in ADTRAN Holdings, Inc. by purchasing 448,848 additional shares, bringing their total to 1.34 million shares, representing 1.66% of the company. Institutional investors now collectively own 80.56% of ADTRAN, despite mixed analyst ratings with a consensus …

Análise e Previsão das Ações da Medtronic PLC (MDT)

Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter …

Notícias das Ações da Medtronic PLC (MDT)

Medtronic PLC (MDT) Aktuelle Aktien-News

Medtronic gets CE mark for ablation to treat ventricular tachycardia

Medtronic has received an expanded CE mark for its Affera mapping and ablation system and Sphere-9 catheter to treat ventricular arrhythmias, including ventricular tachycardia. The Sphere-9 catheter also recently received breakthrough device designation from the FDA, acknowledging the need for more effective treatments for …

Palouse Capital Management Inc. Acquires 29,275 Shares of Medtronic PLC $MDT

Palouse Capital Management Inc. significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, acquiring an additional 29,275 shares to bring its total holdings to 57,027 shares valued at approximately $4.46 million. This move comes as Medtronic exceeded analyst expectations with its …

180 Wealth Advisors LLC Lowers Holdings in Medtronic PLC $MDT

180 Wealth Advisors LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 75% in the second quarter, selling 29,822 shares and retaining 9,951 shares valued at $778,000. Despite this reduction, Medtronic reported strong quarterly results with revenue of $9.81 billion and adjusted EPS …

Balefire LLC Sells 25,744 Shares of Medtronic PLC $MDT

Balefire LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 67.1% in the second quarter, selling 25,744 shares but still retaining 12,614 shares valued at $987,000. Despite this institutional sell-off and recent price target reductions by analysts, Medtronic holds a "Moderate Buy" consensus …

ADTRAN Holdings, Inc. (ADTN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against ADTRAN Holdings, Inc. (ADTN) following the company's preliminary second-quarter 2026 financial results, which reported lower-than-expected revenue and non-GAAP operating margin. These figures fell below the company's previously issued guidance and analyst consensus estimates, leading …

Medtronic’s ablation system lands ventricular arrhythmia indication expansion in Europe

Medtronic's Sphere-9 catheter and Affera mapping and ablation system has secured a CE mark in Europe for ventricular arrhythmia treatment, making it the first all-in-one dual-energy catheter CE marked for this indication. The company is also pursuing US FDA clearance for the system for …

Adtran launches Mosaic One Fabric, empowering operators to build custom AI agents and workflows

Adtran has launched Mosaic One Fabric, an expansion to its Mosaic One software platform, which allows telecommunications operators to create custom AI agents and workflows. This platform enables operators to build and scale AI solutions using their own data and models, rather than being …

ADTRAN Holdings, Inc. Stock 12‑Month Price Target Cut to $15.29, Implies 75% Upside

Analysts have lowered the average 12-month price target for ADTRAN Holdings, Inc. (ADTN) stock from $16.29 to $15.29, based on estimates from 7 analysts, with a range of $11 to $21. This updated target suggests a potential 75% upside from its August 4th closing …

Earnings Release: Here's Why Analysts Cut Their ADTRAN Holdings, Inc. (NASDAQ:ADTN) Price Target To US$14.67

Analysts have cut their price target for ADTRAN Holdings, Inc. (NASDAQ:ADTN) to US$14.67 after the company's second-quarter results. Despite largely unchanged revenue estimates, there was a considerable decrease in expected losses per share. However, analysts appear less optimistic about the overall business, and the …

Medtronic Expands CE Mark Indication For Affera System For Ventricular Arrhythmias Treatment

(RTTNews) - Thursday, Medtronic plc (MDT) announced the expansion of the CE Mark indication for the Affera Mapping and Ablation System with Sphere-9 Catheter to treat ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes. The company stated that the expansion reflects its efforts …

Sphere-9 Maps and Ablates Ventricular Arrhythmias With Two Energies

Medtronic (NYSE: MDT) has announced an expanded CE Mark indication for its Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). The Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, …

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Medtronic has received an expanded CE Mark indication for its Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). This makes the Sphere-9 catheter the first all-in-one mapping and ablation, large-tip focal, …

Canandaigua National Bank & Trust Co. Takes $926,000 Position in Medtronic PLC $MDT

Canandaigua National Bank & Trust Co. has acquired a new stake of 11,842 shares in Medtronic PLC (NYSE:MDT) during the second quarter, valued at approximately $926,000. Medtronic exceeded quarterly expectations with $1.55 EPS and $9.81 billion in revenue, and raised its quarterly dividend to …

Medtronic on the future of AI-assisted surgery

Medtronic is advancing AI-assisted surgery with its new Touch Surgery Aide platform and the Hugo robotic surgery system. The platform, which has received FDA clearance for its first AI algorithm (Instrument Exit Point or IEP), aims to improve surgical safety, quality, and efficiency by …

ADTN Falls 46.2% in 3 Months: Is the Selloff Now Overdone?

Shares of ADTRAN Holdings, Inc. ADTN have tumbled 46.2% over the past three months, reflecting a sharp deterioration in investor sentiment after the company warned that near-term execution challenges would weigh on financial performance. The decline has prompted investors to reassess whether the selloff …

Should Investors Buy ADTN or Wait for Better Execution Signals?

ADTRAN Holdings, Inc. ADTN continues to benefit from favorable long-term networking trends, but near-term execution challenges have made the investment case less straightforward. Investors must weigh strong demand for fiber broadband and AI-driven connectivity against operational headwinds that have pressured profitability and earnings expectations. …